Healthcare provider profile · identity verified

Richard E King, MD

Internal Medicine · MONTEREY, CA · NPI 1144390048

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	595	163
Losartan Potassium	Losartan Potassium	475	128
Levothyroxine Sodium	Levothyroxine Sodium	311	71
Eliquis	Apixaban	291	47
Amlodipine Besylate	Amlodipine Besylate	278	79
Simvastatin	Simvastatin	224	60
Tamsulosin Hcl	Tamsulosin Hcl	206	50
Metoprolol Succinate	Metoprolol Succinate	196	54
Rosuvastatin Calcium	Rosuvastatin Calcium	187	47
Sertraline Hcl	Sertraline Hcl	168	46
Lorazepam	Lorazepam	160	39
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	155	27
Omeprazole	Omeprazole	155	42
Hydrochlorothiazide	Hydrochlorothiazide	140	34
Metformin Hcl	Metformin Hcl	138	39
Prednisone	Prednisone	125	67
Zolpidem Tartrate	Zolpidem Tartrate	119	28
Potassium Chloride	Potassium Chloride	115	34
Furosemide	Furosemide	113	27
Nebivolol Hcl	Nebivolol Hcl	113	22
Gabapentin	Gabapentin	107	32
Pantoprazole Sodium	Pantoprazole Sodium	104	30
Celecoxib	Celecoxib	98	20
Tramadol Hcl	Tramadol Hcl	98	33
Trazodone Hcl	Trazodone Hcl	97	19
Cefuroxime	Cefuroxime Axetil	92	69
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	88	23
Irbesartan	Irbesartan	83	19
Jardiance	Empagliflozin	80	18
Metoprolol Tartrate	Metoprolol Tartrate	80	26
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	79	23
Escitalopram Oxalate	Escitalopram Oxalate	78	23
Allopurinol	Allopurinol	76	22
Mirtazapine	Mirtazapine	74	17
Ozempic	Semaglutide	71	12
Azithromycin	Azithromycin	70	66
Ezetimibe	Ezetimibe	70	20
Synthroid	Levothyroxine Sodium	70	15
Alendronate Sodium	Alendronate Sodium	69	22
Levofloxacin	Levofloxacin	63	46
Olmesartan Medoxomil	Olmesartan Medoxomil	60	15
Finasteride	Finasteride	53	11
Quetiapine Fumarate	Quetiapine Fumarate	51	suppressed
Lisinopril	Lisinopril	49	17
Clopidogrel	Clopidogrel Bisulfate	48	14
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	47	11
Pravastatin Sodium	Pravastatin Sodium	41	11
Glipizide Er	Glipizide	39	12
Amiodarone Hcl	Amiodarone Hcl	38	suppressed
Spironolactone	Spironolactone	37	suppressed
Clonazepam	Clonazepam	35	suppressed
Duloxetine Hcl	Duloxetine Hcl	33	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	32	32
Acetaminophen-Codeine	Acetaminophen With Codeine	31	suppressed
Citalopram Hbr	Citalopram Hydrobromide	31	suppressed
Glipizide	Glipizide	31	suppressed
Valsartan	Valsartan	31	suppressed
Carvedilol	Carvedilol	28	suppressed
Clonidine Hcl	Clonidine Hcl	26	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	26	22
Hydralazine Hcl	Hydralazine Hcl	26	suppressed
Lacosamide	Lacosamide	25	suppressed
Propranolol Hcl	Propranolol Hcl	25	suppressed
Montelukast Sodium	Montelukast Sodium	24	suppressed
Testosterone Cypionate	Testosterone Cypionate	24	suppressed
Alprazolam	Alprazolam	23	suppressed
Atenolol	Atenolol	23	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	23	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	23	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	23	suppressed
Amoxicillin	Amoxicillin	22	19
Bumetanide	Bumetanide	22	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	22	13
Cephalexin	Cephalexin	21	16
Hydroxyzine Hcl	Hydroxyzine Hcl	21	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	21	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	21	suppressed
Levetiracetam	Levetiracetam	20	suppressed
Metronidazole	Metronidazole	20	17
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	19	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	18	14
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	18	14
Estradiol	Estradiol	18	12
Eszopiclone	Eszopiclone	18	suppressed
Methenamine Hippurate	Methenamine Hippurate	18	suppressed
Cholestyramine	Cholestyramine (With Sugar)	17	suppressed
Dutasteride	Dutasteride	17	suppressed
Ipratropium Bromide	Ipratropium Bromide	17	suppressed
Lovastatin	Lovastatin	17	suppressed
Meclizine Hcl	Meclizine Hcl	17	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	16	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	16	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	16	suppressed
Ondansetron Hcl	Ondansetron Hcl	16	suppressed
Raloxifene Hcl	Raloxifene Hcl	16	suppressed
Valacyclovir	Valacyclovir Hcl	16	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	15	suppressed
Dexlansoprazole Dr	Dexlansoprazole	15	suppressed
Meloxicam	Meloxicam	15	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	15	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	14	12
Digoxin	Digoxin	14	suppressed
Donepezil Hcl	Donepezil Hcl	14	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	14	12
Ondansetron Odt	Ondansetron	14	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	14	suppressed
Temazepam	Temazepam	14	suppressed
Testosterone	Testosterone	14	suppressed
Xarelto	Rivaroxaban	14	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	13	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Breo Ellipta	Fluticasone/Vilanterol	13	suppressed
Hydrocortisone	Hydrocortisone	13	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	13	suppressed
Spironolactone-Hctz	Spironolact/Hydrochlorothiazid	13	suppressed
Trulicity	Dulaglutide	13	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	12	suppressed
Fentanyl	Fentanyl	12	suppressed
Flecainide Acetate	Flecainide Acetate	12	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	12	suppressed
Oxycodone Hcl	Oxycodone Hcl	12	suppressed
Paroxetine Hcl	Paroxetine Hcl	12	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	12	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	11	suppressed
Lactulose	Lactulose	11	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error